MA-0204 是一种有效，高选择性，有口服活性的的过氧化物酶体增殖物激活受体 δ (PPARδ) 调节剂，对于人，小鼠和大鼠 PPARδ 的 EC50 分别为 0.4 nM、7.9 nM 和 10 nM。有研究 Duchene 肌营养不良症 (DMD) 的潜力。 Information MA-0204 is a potent, highly selective and orally available modulator of peroxisome proliferator activated receptor δ (PPARδ) with EC50 of 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat PPARδ, respectively. MA-0204 is used as a potential treatment for Duchene Muscular Dystrophy (DMD).